These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Unravelling the Mechanistic Role of Quinazolinone Pharmacophore in the Inhibitory Activity of Bis-quinazolinone Derivative on Tankyrase-1 in the Treatment of Colorectal Cancer (CRC) and Non-small Cell Lung Cancer (NSCLC): A Computational Approach. Okunlola FO; Akawa OB; Subair TI; Omolabi KF; Soliman MES Cell Biochem Biophys; 2022 Mar; 80(1):1-10. PubMed ID: 34453681 [TBL] [Abstract][Full Text] [Related]
8. Tankyrase inhibition sensitizes cells to CDK4 blockade. Foronda M; Tarumoto Y; Schatoff EM; Leach BI; Diaz BJ; Zimmerman J; Goswami S; Shusterman M; Vakoc CR; Dow LE PLoS One; 2019; 14(12):e0226645. PubMed ID: 31891587 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Inhibitor for WNT/β-Catenin Pathway by Tankyrase 1/2 Structure-Based Virtual Screening. Li B; Liang J; Lu F; Zeng G; Zhang J; Ma Y; Liu P; Wang Q; Zhou Q; Chen L Molecules; 2020 Apr; 25(7):. PubMed ID: 32268564 [TBL] [Abstract][Full Text] [Related]
10. PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer. Yakkala PA; Naaz F; Shafi S; Kamal A Expert Opin Ther Targets; 2024 Mar; 28(3):159-177. PubMed ID: 38497299 [TBL] [Abstract][Full Text] [Related]
11. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells. Luo F; Li J; Liu J; Liu K Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753 [TBL] [Abstract][Full Text] [Related]
17. UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway. Hu W; Li M; Chen Y; Gu X J Ovarian Res; 2021 Sep; 14(1):121. PubMed ID: 34535173 [TBL] [Abstract][Full Text] [Related]
18. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer? Prossomariti A; Piazzi G; Alquati C; Ricciardiello L Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125 [TBL] [Abstract][Full Text] [Related]
19. Targeting mTOR network in colorectal cancer therapy. Wang XW; Zhang YJ World J Gastroenterol; 2014 Apr; 20(15):4178-88. PubMed ID: 24764656 [TBL] [Abstract][Full Text] [Related]